Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges
Neuropeptide Y (NPY) is a 36-amino-acid peptide member of a family also including peptide
YY and pancreatic polypeptide, which are all ligands to Gi/Go coupled receptors. NPY …
YY and pancreatic polypeptide, which are all ligands to Gi/Go coupled receptors. NPY …
Neuropeptide Y and chronic kidney disease progression: a cohort study
C Zoccali, G D'arrigo, D Leonardis… - Nephrology Dialysis …, 2018 - academic.oup.com
ABSTRACT Background Neuropeptide Y (NPY) is a sympathetic neurotransmitter that has
been implicated in various disorders including obesity, gastrointestinal and cardiovascular …
been implicated in various disorders including obesity, gastrointestinal and cardiovascular …
Role of neuropeptide Y in the regulation of kidney function
J Winaver, Z Abassi - NPY family of peptides in neurobiology …, 2006 - Springer
Neuropeptide Y (NPY), a 36-residue peptide is a sympathetic co-transmitter stored and
released together with noradrenaline by adrenergic nerve terminals of the sympathetic …
released together with noradrenaline by adrenergic nerve terminals of the sympathetic …
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study
C Zoccali, G D'Arrigo, D Leonardis, P Pizzini… - Journal of …, 2019 - journals.lww.com
Background: Neuropeptide Y (NPY) is a multifaceted sympathetic neurotransmitter
regulating reflex cardiovascular control, myocardial cell growth, inflammation and innate …
regulating reflex cardiovascular control, myocardial cell growth, inflammation and innate …
Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease
Chronic renal insufficiency is a situation characterized by high plasma concentration of
neuropeptide Y (NPY). Because this neuropeptide interferes with cardiovascular (CV) …
neuropeptide Y (NPY). Because this neuropeptide interferes with cardiovascular (CV) …
Neuropeptide Y gene polymorphisms and chronic kidney disease progression
B Spoto, F Mallamaci, C Politi… - Journal of …, 2024 - journals.lww.com
Background: Neuropeptide Y (NPY) is a neurotransmitter expressed in both the central and
peripheral nervous systems, which is involved in regulating a multitude of physiological …
peripheral nervous systems, which is involved in regulating a multitude of physiological …
Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease
L Lu, YC Zou, M Wang, YF Huang, DX Chen… - European Journal of …, 2015 - nature.com
Results: CSF NpY levels and nutritional indices were related during CKD progression
(energy intake: β= 0.236, P< 0.001; mid-arm muscle circumference: β= 0.953, P= 0.014; …
(energy intake: β= 0.236, P< 0.001; mid-arm muscle circumference: β= 0.953, P= 0.014; …
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes
K McDowell, C Adamson, C Jackson… - European Journal of …, 2024 - Wiley Online Library
Abstract Aims Neuropeptide Y (NPY) is the most abundant neuropeptide found in the heart
and is released alongside norepinephrine following prolonged sympathetic activation, a …
and is released alongside norepinephrine following prolonged sympathetic activation, a …
Cross talk about the role of Neuropeptide Y in CNS disorders and diseases
R Bale, G Doshi - Neuropeptides, 2023 - Elsevier
A peptide composed of a 36 amino acid called Neuropeptide Y (NPY) is employed in a
variety of physiological processes to manage and treat conditions affecting the endocrine …
variety of physiological processes to manage and treat conditions affecting the endocrine …
Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
J Pons, EW Lee, L Li, J Kitlinska - Current opinion in investigational …, 2004 - europepmc.org
Neuropeptide Y (NPY), a sympathetic co-transmitter, acts through multiple G protein-coupled
receptors (Y1 to y6) to elicit its vast range of effects in the cardiovascular, immune, and …
receptors (Y1 to y6) to elicit its vast range of effects in the cardiovascular, immune, and …
相关搜索
- kidney disease cognitive dysfunction
- kidney disease translational opportunities
- renal disease risk factor
- translational opportunities cognitive dysfunction
- risk factor cognitive dysfunction
- translational opportunities risk factor
- kidney disease cardiovascular events
- renal disease end stage
- kidney disease neuropeptide y levels
- kidney disease nutritional status
- risk factor end stage
- cardiorenal disease cognitive dysfunction
- kidney disease risk factor
- cardiorenal disease translational opportunities
- cardiorenal disease risk factor